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Abstract: The antigenic diversity of Orientia tsutsugamushi as well as the interstrain difference(s)
associated with virulence in mice impose the necessity to dissect the host immune response. In this
study we compared the host response in lethal and non-lethal murine models of O. tsutsugamushi
infection using the two strains, Karp (New Guinea) and Woods (Australia). The models included the
lethal model: Karp intraperitoneal (IP) challenge; and the nonlethal models: Karp intradermal (ID),
Woods IP, and Woods ID challenges. We monitored bacterial trafficking to the liver, lung, spleen,
kidney, heart, and blood, and seroconversion during the 21-day challenge. Bacterial trafficking to all
organs was observed in both the lethal and nonlethal models of infection, with significant increases
in average bacterial loads observed in the livers and hearts of the lethal model. Multicolor flow
cytometry was utilized to analyze the CD4+ and CD8+ T cell populations and their intracellular
production of the cytokines IFNγ, TNF, and IL2 (single, double, and triple combinations) associated
with both the lethal and nonlethal murine models of infection. The lethal model was defined
by a cytokine signature of double- (IFNγ-IL2) and triple-producing (IL2-TNF-IFNγ) CD4+ T-cell
populations; no multifunctional signature was identified in the CD8+ T-cell populations associated
with the lethal model. In the nonlethal model, the cytokine signature was predominated by CD4+
and CD8+ T-cell populations associated with single (IL2) and/or double (IL2-TNF) populations of
producers. The cytokine signatures associated with our lethal model will become depletion targets in
future experiments; those signatures associated with our nonlethal model are hypothesized to be
related to the protective nature of the nonlethal challenges.
Keywords: scrub typhus; Orientia tsutsugamushi; mouse model; T cells; cytokines; lethality; protection

iations.

1. Introduction
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
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Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
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Orientia tsutsugamushi, an obligate, intracellular bacterium, is the causative agent of
scrub typhus. Scrub typhus is a febrile disease, endemic to the Asia-Australia-Pacific region,
with case fatality rates of up to 50% in untreated patients. In indigenous areas, scrub typhus
can account for up to 19% of all illnesses and 23% of febrile illnesses [1]. The disease is transmitted to humans through the bite of infected chigger mites (Leptotrombidium spp.), and can
lead to the production of an eschar at the bite site. Symptoms of the disease include fever,
rash, pneumonitis, meningitis, and intravascular coagulation. The disease can be treated
with doxycycline, tetracycline, or chloramphenicol. In vivo and in vitro, the bacteria can
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infect host cells that include macrophages, polymorphonuclear leukocytes, lymphocytes
and endothelial cells [2–4]. Recent studies have shown the involvement of the NOD1-IL32
pathway in the production of inflammatory cytokines during O. tsutsugamushi infection [5];
the ability of O. tsutsugamushi to avoid autophagic defenses by host cells [6,7]; the necessity
of IL1R signaling for host defense against O. tsutsugamushi and inflammasome activation in
response to O. tsutsugamushi uptake [8]; the association of O. tsutsugamushi with lipid rafts
during budding/exit from cells (but not during entry) [9]; and the upregulation of type 1
IFN genes, interferon-stimulated genes, and/or inflammatory cytokines/chemokines in
infected human macrophages, characterized by a M1 polarization of macrophages [10].
Despite the advances in better defining the pathways/mechanisms that O. tsutsugamushi
utilizes, no long lasting, broadly protective vaccine against scrub typhus has yet been
developed [1]. Moreover, reports of scrub typhus not responding to appropriate antibiotic
treatment are of concern [11]. Approximately one million cases of scrub typhus are reported
each year in endemic areas, and this includes those cases reported among United States
military personnel who are deployed/stationed overseas [12].
It is known that control of scrub typhus infections is under the regulation of both the
cellular and humoral immune responses. The early immune response in mice includes
macrophage- and dendritic cell-mediated cellular immunity, and is crucial to the clearance
of infection [13,14]. Cell mediated immunity in mice has also been described in studies
demonstrating protection from passive transfer of enriched spleen cells or T-cells [13–19],
production of antigen specific lymphocytes [20–22], and delayed type hypersensitivity after
immunization [16]. A humoral immune response during O. tsutsugamushi infections in
mice has also been shown, e.g., antibody production from infection [15,23] and inhibition
of establishment of infection in target cells by immune serum [24]. However, antibody
production alone does not confer protection, as immunization of mice with irradiated
O. tsutsugamushi protected against homologous/heterologous challenge, but minimal
antibody response to the vaccination was observed [25].
Development of a successful vaccine will ultimately require a complete understanding
of the host immune response, which includes detailing the profile(s) of immune cells that
are elicited during O. tsutsugamushi infections. It has been suggested that the interactions
of populations of immune cells such as T-cells, natural killer cells, dendritic cells, and
macrophages, and how they relate to cytokine/chemokine production in vivo are a key
component in the development of a scrub typhus vaccine [26,27] Studies aimed at defining
the immune cell populations following infection with O. tsutsugamushi have been performed, particularly using human samples. One study performed flow cytometry analysis
of patients’ immune cells during the acute and convalescent phases of disease to better
define leukocyte populations [28]. Neutrophilia and CD4+ T lymphopenia (including
Treg cells) were observed during the acute phase of infection; increases in CD8+ cells
were noted during the convalescent phase; and no changes in natural killer cells were
noted [28]. Eschar skin biopsies from scrub typhus patients have also been analyzed using
immunohistochemistry and microscopy tools to determine the phenotypes of infected host
cells [28]. Within the eschar, O. tsutsugamushi-infected cells were found to be predominantly
monocyte/macrophages and dermal dendritic cells, along with a smaller proportion of
CD3+ T-cells. Further studies are needed to fully delineate the phenotypes of cells elicited
during infection and their potential role(s) in the host immune response.
More than 20 antigenically distinct strains of O. tsutsugamushi have been reported to
date [1,29]. The antigenic diversity of O. tsutsugamushi as well as the interstrain differences
in virulence exhibited in mice enhance the necessity to dissect the host immune response.
Murine susceptibility to O. tsutsugamushi infection and subsequent disease is dependent
upon multiple variables, including challenge route, mouse strain, and O. tsutsugamushi
strain. In particular, the intraperitoneal (IP) route of infection with the Karp strain of O.
tsutsugamushi has been shown to consistently result in severe illness/death in a variety of
inbred, outbred, and crossbred strains of mice [30]. Other strains of human pathogenic
O. tsutsugamushi (e.g., Gilliam, Woods) administered by the IP route have shown various
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degrees of severe to moderate disease in the mouse model [30]. Intravenous (IV) models
of infection in inbred mice have been shown to mimic the pathology of human scrub
typhus cases [31–33] (IP models contrastingly result in peritonitis); however, IV models
do not replicate the natural mode of infection (chigger to human). Intradermal models
of infection, while mimicking chigger to human transmission, result in delayed bacterial
trafficking and onset of clinical symptoms, and rarely cause lethality. In this study, the IP
model was selected for lethal versus non-lethal analysis due to its reliability as a method
that consistently provides both lethal (Karp strain) and non-lethal (Woods) infections.
We hypothesized that distinct cytokine signatures within T-cell populations could be
determined when comparing the lethal model (O. tsutsugamushi Karp intraperitoneal
injection (Karp IP)) to nonlethal models (O. tsutsugamushi Karp intradermal injection (Karp
ID), Woods intraperitoneal injection (Woods IP), and Woods ID) using multicolor flow
cytometry to detect the prevalence of interferon gamma (IFNγ), interleukin 2 (IL2), and/or
tumor necrosis factor alpha (TNF) producing T-cell populations. Interstrain (Karp IP to
Woods IP or Karp IP to Woods ID) and intrastrain (Karp IP to Karp ID) model comparisons
were made at distinct time points based upon the severity of illness in the mice: (1) Karp
IP, 10 days—onset of severe illness; (2) Karp IP, 14 days—severe illness; (3) Karp ID,
10, 14, 21 days and Woods IP, ID, 10, 21 days—mild to no illness. The classification of
cytokine signatures associated with both the lethal and nonlethal models of murine O.
tsutsugamushi infection will aid in contributing to a better understanding of the various
clinical signs and symptoms associated with scrub typhus infections and in the deduction
of the immunopathological mechanisms related to lethality and protection from disease.
2. Materials and Methods
2.1. Mice and Orientia tsutsugamushi Infections
CD-1 Swiss outbred mice (female, 6–8 weeks of age) were purchased from Charles
River Laboratories, Inc. (Wilmington, MA, USA). Mice were initially housed in animal
biosafety level (ABSL)-2 laboratories and were transferred to an ABSL-3 laboratory for
adaptation one week prior to challenge experiments. Mice were inoculated either intraperitoneally (IP) or intradermally (ID) with103 MuID50 of O. tsutsugamushi strain Karp (Papua
New Guinea) or Woods (Australia) as previously described [34]. For all ID inoculations,
mice were anesthetized using isofluorane (inhalation administration). ID injections of 103
MuID50 of O. tsutsugamushi were performed at the right ear dorsum at a single site (5 µL of
pre-titrated liver-spleen homogenate) using a 0.3 mL insulin syringe (Becton Dickinson,
NJ, USA). Negative control animals received an IP or ID inoculation of sterile PBS buffer.
Following inoculation, the mice were observed for signs of systemic disease for 21 days.
Mice (n = 3–8 per group/time point) were euthanized at 10, 14 (Karp IP only), and/or 21
days following infection. All animal experimentation was performed under the approval
of the Institutional Animal Care and Use Committee at the Naval Medical Research Center,
Silver Spring, MD (Protocol Number: 11-IDD-26).
2.2. O. tsutsugamushi qPCR Assay
O. tsutsugamushi was detected in the liver, lung, spleen, kidney, heart, and blood at
each time point using a previously described qPCR assay for the Orientia-specific 47 kDa
gene [35]. Templates were based on genomic DNA extracted from the aforementioned
organs using the Bullet Blender Blue (Next Advance, Inc., Averill Park, NY, USA) and the
DNeasy tissue kit (Qiagen, Valencia, CA, USA) according to the manufacturer’s protocols.
Reactions were performed using the Platinum qPCR UDG Supermix kit (Life Technologies, Carlsbad, CA, USA) and all qPCR assays were performed in an ABI StepOne Plus
thermocycler (Foster City, CA, USA). For normalization of O. tsutsugamushi copy numbers,
a qPCR assay (Integrated DNA Technologies, Inc., Coralville, IA, USA) for the mouse
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene was used: forward primer
50 -AACTTTGGCATTGTGGAAGG-30 , reverse primer 50 -ACACATTGGGGGTAGGAACA30 , and probe 50 -FAM-ACCCAGAAGACTGTGGATGG-30 . The relative O. tsutsugamushi
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genome levels were calculated after normalization to the GAPDH gene(s) using a standard curve that was constructed using 10-fold dilutions of known concentrations of an O.
tsutsugamushi 47 kDa target sequence cloned into a plasmid, as previously described [36].
For negative controls, qPCR reactions of organs collected from uninfected mice and reactions containing no DNA template were included with each qPCR run. No copies of O.
tsutsugamushi were detected in the negative controls.
2.3. ELISAs
Serum samples from mice at all time points were analyzed for the presence O. tsutsugamushi-specific antibodies (total IgG) as previously described [36]. Whole cell antigen
(0.3 µg/100 µL; 0.1 µg from each strain of O. tsutsugamushi (Karp, Gilliam, and Woods)
(diluted in sterile PBS) was passively adsorbed onto each well of one half of a 96-well plate
(Dynatech Laboratories Inc., Chantilly, VA, USA). PBS (no antigen) was added to the other
half of the 96-well plate. Coated plates were incubated at 4 ◦ C in a refrigerator for at least
48 h, and then washed three times with 300 µL/well of wash buffer (PBS containing 0.1%
Tween 20 (Sigma Chemical Co., St. Louis, MO, USA)). Plates were blocked with wash
buffer containing 5% skim milk for 1 h at room temperature and then washed three times.
Serum samples were serially diluted (four-fold dilutions from 1:100 to 1:6400) in wash
buffer containing 5% skim milk to a final volume of 100 µL/well and incubated at room
temperature for 1 h, and then were washed three times with wash buffer. The presence
of specific antibodies was demonstrated by the subsequent binding of 100 µL/well of
horseradish peroxidase-conjugated goat antibodies directed to mouse immunoglobulin
G (IgG) (Kirkegaard and Perry Laboratories, Gaithersburg, MD, USA). The plates were
incubated at room temperature for 1 h, washed, and 100 µL/well substrate (equal volumes of 2,20 -azino-di-(3-ethylbenzthiazoline-6-sulfonate) (ABTS) and hydrogen peroxide
(Kirkegaard and Perry Laboratories)) were added to each well. The plates were incubated at
room temperature for 15 min. Optical densities at 405 nm were measured by Vmax/Kinetic
Microplate Reader (Molecular Devices, Sunnyvale, CA, USA). Titers were expressed as
the inverse of the highest dilution in which a net optical density (absorbance with antigen
minus absorbance without antigen) of 0.200 or greater was obtained. The mean net absorbance plus 3 standard deviations of three negative control sera was consistently less
than an optical density of 0.200.
2.4. Flow Cytometry
At 10, 14 and 21 days following challenge, mice were euthanized and the spleens were
processed into cell suspensions containing 1 × 107 cells/mL in RPMI 1640 (Life Technologies) supplemented with 10% FBS and 50 µm BME. One million spleen cells were plated in
a round bottom 96-well plate and stimulated with 1.5 µg of Kpr47 O. tsutsugamushi antigen
(recombinant full-length 47 kDa protein from the Karp strain, produced by Invitrogen,
Waltham, MA, USA) (experimental groups), 2 µg of ConA (positive control) or no stimulation (negative control) and were incubated for 2 h at 37 ◦ C. Following incubation, 1 µL/mL
of Golgi Plug (BD Biosciences, Franklin Lakes, NJ, USA) was added to the wells and the
cells were incubated for 4 h at 37 ◦ C and then transferred to 4 ◦ C overnight. Cells were
surface stained for 1 h at 4 ◦ C with anti-mouse CD3 Alexa 700 (BD #557984), anti-mouse
CD4 PerCP (BD #553052), and anti-mouse CD8 Pacific Blue (BD #558106). Cells were then
permeabilized using the Cytofix/Cytoperm kit according to manufacturer’s instructions
(BD #555029) and stained intracellularly for 2 h at 4 ◦ C (in the dark) with anti-mouse IFNγ
APC (BD #554413), anti-mouse IL2 FITC (BD #554427), and anti-mouse TNFα (BD #554419).
Cells were washed in Perm/Wash Buffer (BD), resuspended in PBS, and acquired on an
LSRII (BD Biosciences). Data were analyzed using FlowJo software version 7.6.5 (FLOJO
LLC, Ashland, OR, USA).
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2.5. Statistical Analysis
Comparisons between lethal and nonlethal experimental groups were performed
using Students two-tailed t-test and/or Spearman’s Rank Correlation. A p value of ≤0.05
was considered significant. All statistical analyses were performed using Microsoft Excel
365 (2016), GraphPad Prism 7 (GraphPad Software, Inc., La Jolla, CA, USA), and/or R
version 3.2.3.
3. Results
3.1. Clinical Observation and Morbidity/Mortality in Differentially Challenged Mice
The course of infection in mice challenged IP with O. tsutsugamushi Karp or Woods, or
challenged ID with O. tsutsugamushi Karp or Woods was monitored for up to 21 days post
infection (twice per day). No eschar formation and/or reaction at the injection site were
observed in any of the differentially challenged mice, similar to previous studies [34,37].
Mice challenged IP with the Karp strain began to display signs of illness at 7 days post
infection (dpi), including ruffled fur in 25% of the animals. By 9 dpi, 100% of the animals
displayed ruffling of the fur and markedly slower movement. Mice became very ill
by 12 dpi and displayed symptoms that included bloody noses, hunched posture, and
difficulty in locomotion; very ill mice were euthanized in accordance with the approved
IACUC protocol. At 14 dpi, 40% of mice challenged by Karp IP were alive and by 21 dpi,
20% of mice were alive (n = 1) (Figure 1). For those mice challenged ID with Karp, 100%
survival was observed throughout the 21 day challenge experiment (Figure 1). The only
outward symptom of illness displayed by the mice challenged ID with Karp was a slight
ruffling of the fur beginning at 17 dpi in 40% of the animals and continuing in 100% of
the animals from 19–21 dpi. Despite the ruffled fur, all Karp ID challenged animals were
bright, alert, and reactive.

Figure 1. Comparison of survival in lethal and nonlethal murine models of O. tsutsugamushi infection, based upon strain
and challenge route. All animals challenged with strain Woods (intraperitoneally (IP) or intradermally (ID)) and with strain
Karp (ID) survived. Animals challenged with strain Karp (IP) demonstrated 40% and 20% survival at 14 dpi and 21 dpi,
respectively.

When mice were challenged with O. tsutsugamushi Woods, either IP or ID, 100%
survival was observed during the 21 day challenge experiment (Figure 1). In the Woods
IP challenged animals, we observed mildly ruffled fur in 100% of the animals at 17 dpi.
At 18 dpi, the mildly ruffled fur was accompanied by abdominal bloating in 100% of the
animals; these symptoms lasted until the end of the challenge experiment (21 dpi) (Table 1).
In the ID challenged animals, abdominal bloating was observed in 100% of the animals
from 19–21 dpi. Despite the observed symptoms in the IP and ID challenged animals, no
behavioral changes were observed in any of the animals.
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Table 1. Visual observations of affected organs observed in O. tsutsugamushi ID Karp- or Woodschallenged mice (compared to control animals) at the time of necropsy (10 and 21 dpi). The number
of mice with affected organs (numerator) out of the total mice in the group (denominator) is indicated
for each specific observation.
10 dpi

Enlarged spleen
Fluid in peritoneum
Pale liver
Pale kidney
Pale heart
Enlarged stomach
Enlarged liver
Enlarged lungs

21 dpi

Karp ID

Woods ID

Karp ID

Woods ID

5/5
1/5

7/7
1/7

5/5
2/5

7/7

5/5

5/5
5/5

At the time of necropsy, visual inspections of the spleen, kidneys, liver, lungs, heart,
and stomach were compared/recorded between challenged and control animals. In the IP
Karp-challenged animals (n = 5), accumulation of bloody fluid in the peritoneum (100% of
mice), enlarged spleens (2–3 times the size of control animals; 100% of mice), pale coloration
of the liver (100% of mice), pale coloration of the kidneys (20% of mice), and pale coloration
of the heart (20% of mice) were observed (Table 2). At 14 dpi, all IP Karp-challenged
mice were very ill at the time of necropsy. In these animals, swelling of the stomach,
enlarged spleen (1.5–2 times the size of control animals), pale coloration of the liver, and
accumulation of bloody fluid in the peritoneum were observed (100% of animals) (Table 2).
By 21 dpi, a single Karp-IP challenged mouse remained alive and displayed symptoms
such as ruffled fur and decreased activity. During necropsy bloody fluid in the peritoneum,
enlarged spleen (5–6 times the size of control mice), pale coloration of the kidneys, and
enlargement of the liver and lungs were observed (Table 2). In the ID Karp-challenged
mice at 10 dpi, enlarged spleens (2–3 times the size of control mice; 100% of mice) and a
small amount of bloody fluid in the peritoneum (20% of mice) were observed (Table 1).
At 21 dpi, the ID Karp-challenged mice displayed enlarged spleens (4–6 times the size of
control mice; 100% of mice), enlargement of the liver and lungs (100% of mice), pale color
of the kidneys (100% of mice), and a small amount of bloody fluid in the peritoneum (40%
of mice) (Table 1).
Table 2. Visual observations of affected organs observed in O. tsutsugamushi IP Karp- or Woodschallenged mice (compared to control animals) at the time of necropsy (10, 14, and 21 dpi). The
number of mice with affected organs (numerator) out of the total mice in the group (denominator) is
indicated for each specific observation.
10 dpi

Enlarged spleen
Fluid in peritoneum
Pale liver
Pale kidney
Pale heart
Enlarged stomach
Enlarged liver
Enlarged lungs

14 dpi

21 dpi

Karp IP

Woods IP

Karp IP

Karp IP

5/5
5/5
5/5
1/5
1/5

5/7
1/7

3/3
3/3
3/3

1/1

Woods IP
7/8

1/1
3/3

1/8
1/1
1/1

Visual inspection of the organs in the Woods IP-challenged animals as compared to the
control animals at 10 dpi revealed enlarged spleens (2–3 times the size of control animals;
71% of mice) and bloody fluid in the peritoneum (14% of mice) (Table 2); visual inspection
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of two of the mice did not reveal any differences in organs compared to control animals. At
21 dpi, the Woods IP-challenged animals showed enlarged spleens (4–5 times the size of
control animals; 87.5% of mice) and an enlargement of stomach and small intestines (12.5%
of mice) (Table 2); visual inspection of one of the mice did not reveal any differences in
organs compared to control animals. In the Woods ID-challenged mice at 10 dpi, enlarged
spleens were observed (2–3 times the size of control animals; 100% of mice) and a small
amount of bloody fluid in the peritoneum (14% of mice) (Table 1). At 21 dpi, enlarged
spleens were observed in all of the Woods ID-challenged mice (3–4 times the size of control
mice; 100% of mice) (Table 1).
3.2. Determination of Antibody Titer in O. tsutsugamushi-Infected Mice
The antibody response against O. tsutsugamushi (total IgG) was assayed at all time
points (10, 14, and 21 dpi) in each mouse. No O. tsutsugamushi-specific antibodies were
detected in any of the negative control mice. At 10 dpi, seroconversion was not detected in
mice from any of the challenge groups (Karp IP, ID or Woods IP, ID) (Figure 2). At 14 dpi,
100% of mice (n = 3) in the Karp IP-challenge group displayed seroconversion (each with
a titer of 1:1600) (Figure 2). At 21 dpi, 100% of mice in all challenge groups displayed
seroconversion: the single surviving Karp-IP challenged mouse displayed a titer of 1:6400;
in the Karp ID-challenge group (n = 5), 20% of mice displayed a titer of 1:1600 and 80%
displayed titers of 1:6400; in the Woods IP-challenge group, 100% of mice (n = 8) displayed
titers of 1:6400; and in the Woods ID-challenge group (n = 7), 71% of mice displayed titers
of 1:1600 and 29% of mice displayed titers of 1:6400 (Figure 2).

Figure 2. Detection of O. tsutsugamushi-specific IgG in serum of challenged mice at 10, 14, and 21 dpi.
At 10 dpi, IgG was not detected in any of the challenged mice. At 14 dpi, 100% of Karp IP mice
(n = 3) (only mice assessed at 14 dpi). At 21 dpi, 100% of the mice (all strains and challenge routes)
(n = 5–8) displayed seroconversion. No O. tsutsugamushi-specific antibodies were detected in any of
the negative control mice (data not shown).

3.3. Bacterial Trafficking of O. tsutsugamushi in Lethal and Nonlethal Models of O. tsutsugamushi
Infection
A qPCR assay for the Orientia-specific 47 kDa gene [35] was used to assess the bacterial
loads in spleen, liver, lung, kidney, heart, and blood samples collected from each mouse
in the lethal (Karp IP) and nonlethal groups (Karp ID, Woods IP, and Woods ID) at each
time point throughout the experiment (10, 14, and 21 dpi). Bacterial loads were measured
in all organs in the lethal and nonlethal models at 10, 14, and 21 dpi; the lethal model (10
and 14 dpi) displayed increased bacterial loads in all organs compared to the nonlethal
models (Figure 3). In the lethal model, the highest average bacterial loads were detected
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in the blood, liver, and lungs at both 10 dpi and 14 dpi. In the nonlethal models (Karp ID,
Woods IP, and Woods ID), the highest average bacterial loads were detected in lungs or
kidneys (Figure 3). Significant differences between the lethal and nonlethal models were
only observed in bacterial loads found in the liver and/or the heart (Figure 3). Intrastrain
comparisons revealed a significantly increased average bacterial load in the livers and
hearts of the lethal model (Karp IP) at 10 dpi (start of severe illness) when compared to
the nonlethal model (Karp ID) at 14 dpi or 21 dpi. By 14 dpi (severe illness) in the lethal
model, a significant increase in the average bacterial load in the heart was detected when
compared to mice in the nonlethal group at 21 dpi (Figure 3). Similar significant trends
were observed during interstrain comparisons: (1) significantly increased average bacterial
loads were observed in the livers and hearts of mice in the lethal group (Karp IP, 10 dpi)
when compared to the nonlethal models Woods IP (21 dpi) and Woods ID (10 and 21 dpi);
(2) significantly increased average bacterial loads were observed in the livers of mice in the
lethal group (Karp IP, 10 dpi) when compared to the nonlethal model Woods IP (10 dpi);
and (3) significantly increased average bacterial loads were observed in the hearts of mice
in the lethal group (Karp IP, 14 dpi) when compared to the nonlethal models Woods IP
(21 dpi) and Woods ID (21 dpi) (Figure 3).

Figure 3. Bacterial trafficking of O. tsutsugamushi in the lethal (Karp IP) and nonlethal (Karp ID, Woods IP, Woods ID)
models of O. tsutsugamushi infection at 10, 14, and/or 21 dpi. Significant differences between average bacterial loads in the
lethal and nonlethal models are indicated by asterisks (*, p < 0.05).

3.4. Multifunctional Cytokine Analysis of O. tsutsugamushi-Specific CD4+ and CD8+ T Cells
In order to identify the cytokine signatures associated with the lethal or nonlethal
model(s) of O. tsutsugamushi infection, multifunctional cytokine analysis of O. tsutsugamushi-specific CD4+ and CD8+ T cells was performed. Seven combinations of three
cytokines (IFNγ, IL2, TNF, IFNγ-IL2, IFNγ-TNF, IL2-TNF, IL2-TNF-IFNγ) associated with
CD4+ or CD8+ T-cell populations were compared between the lethal and nonlethal models
(Figures 4 and 5).
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Figure 4. Multifunctional cytokine analysis of O. tsutsugamushi-specific CD4+ T cells represented by the frequency of
cytokine (single, double, or triple) positive cells for the lethal (Karp IP) and nonlethal (Karp ID, Woods IP, and Woods ID)
models of murine O. tsutsugamushi infection. The intracellular cytokine profiles for IFNγ, IL2, and TNF in individual cells
were measured by multicolor flow cytometry with gating for CD4+ or CD8+ T cells. All possible combinations of cytokines
are shown on the x-axis; the frequency of each population is shown as the mean ± SD on the y-axis.

Figure 5. Multifunctional cytokine analysis of O. tsutsugamushi-specific CD8+ T cells represented by the frequency of
cytokine (single, double, or triple) positive cells for the lethal (Karp IP) and nonlethal (Karp ID, Woods IP, and Woods ID)
models of murine O. tsutsugamushi infection. The intracellular cytokine profiles for IFN, IL2, and TNF in individual cells
were measured by multicolor flow cytometry with gating for CD4+ or CD8+ T cells. All possible combinations of cytokines
are shown; the frequency of each population is shown as the mean.
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Cytokine production by individual cells of CD4+ T-cell populations in the lethal challenge groups was dominated by the triple production of IL2-TNF-IFNγ and the double
production of IFNγ-IL2, IFNγ-TNF, and/or IL2-TNF at both 10 and 14 dpi; T-cell populations producing single cytokines comprised the smallest proportion of both of the lethal
challenge groups (Figure 4). With one exception (Karp ID, 14 dpi), the dominance of
triple producers was not observed in the nonlethal models (Karp ID, 21 dpi; Woods IP 10,
21 dpi; and Woods ID 10, 21 dpi) (Figure 4). Instead, double producers (IFNγ-TNF and/or
IL2-TNF) tended to dominate the CD4 T-cell populations in the majority of the nonlethal
groups (Karp ID, 21 dpi; Woods IP, 10, 21 dpi; Woods ID 10, 21 dpi) (Figure 4). Additionally
in the nonlethal groups, single producers (IL2 and TNF) comprised a larger proportion of
the CD4+ T-cell populations in several instances: Karp ID, 14 dpi (TNF); Karp ID, 21 dpi
(TNF); Woods IP, 21 dpi (IL2); and Woods ID, 21 dpi (IL2) (Figure 4).
In distinct contrast, cytokine production by CD8+ T-cells in the lethal groups was
not dominated by triple cytokine producing cells; in fact, the frequencies of the triple
cytokine producing population were among the lowest in both of the lethal groups (Karp
IP, 10 and 14 dpi) (Figure 5). Instead the lethal groups were dominated by CD8+ cytokine
populations composed of primarily double (IL2-TNF) and single (IL2 and TNF) producers.
Comparatively, in all instances but one (Woods IP, 10d), we also observed enhanced
frequencies of single producers (IL2 and/or TNF); double producers (IL2-TNF) were also
dominant among the CD8+ T-cell populations in all of the nonlethal groups (Figure 5).
The observed differences in dominance of triple, double, and single cytokine producing T-cell populations aligned with the hypothesis that distinct cytokine signatures could
be associated with the lethal and nonlethal models of O. tsutsugamushi.
3.5. CD4+ and CD8+ T-Cell Cytokine Signatures of Lethality or Non-Lethality (Protection)
Cytokine signatures were determined by identifying the significant differences in
CD4+ or CD8+ cytokine populations when comparing the lethal (Karp IP, 10 and 14 dpi)
and nonlethal (Karp ID, 14 and 21 dpi; Woods IP, 10 and 21 dpi; Woods ID, 10 and
21 dpi) models of O. tsutsugamushi infection (Figure 6). Intra- and interstrain comparisons
were made by comparing the lethal groups at the start of severe illness (10 dpi) or at a
peak in severe illness (14 dpi) to each of the nonlethal groups (Figure 6). The observed
significant differences in T-cell cytokine populations were defined as signatures of lethality
or protection when they: (1) occurred in more than one experimental group of animals
(lethal vs. nonlethal), thereby indicating a trend in production; and (2) demonstrated
significant difference from the respective sham controls; i.e., those differences identified
as significant in either the lethal or nonlethal groups also differed significantly from the
sham controls.
When performing intra- and interstrain comparison of the CD4+ T-cell populations
associated with the lethal and nonlethal models (Figure 6), significant differences in IFNγIL2 (double producers) and IL2-TNF-IFNγ (triple producers) cytokine populations were
observed in the lethal model (Figure 7), thereby defining the lethal cytokine signature.
Intrastrain comparisons revealed significant increase in IFNγ-IL2 production in the lethal
model at 10 dpi compared to the nonlethal models at 14 and 21 dpi (Figure 7A). Intrastrain
comparisons also revealed significant increases in IL2-TNF-IFNγ production in the lethal
model at 10 and 14 dpi compared to the nonlethal model at 21 dpi (Figure 7A). In both interstrain comparisons, significant increases in IFNγ-IL2 and IL2-TNF-IFNγ were observed
in the lethal model at 10 and 14 dpi when compared to nonlethal models at both 10 and
21 dpi (Figure 7B,C).
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Figure 6. Multifunctional cytokine analysis of O. tsutsugamushi-specific CD4+ or CD8+ T cells represented by the frequency
of cytokine (single, double, or triple) positive cells. Inter- and intrastrain comparisons are shown for the lethal (Karp IP)
and nonlethal (Karp ID, Woods IP, and Woods ID) models of murine O. tsutsugamushi infection. The intracellular cytokine
profiles for IFNγ, IL2, and TNFα in individual cells were measured by multicolor flow cytometry with gating for CD4+ or
CD8+ T cells. All possible combinations of cytokines are shown on the x-axis; the frequency of each population is shown as
the mean ± SD on the y-axis.

Figure 7. CD4 lethal cytokine signature. (A) Intrastrain comparisons revealed significant increase in IFN-IL2 production
in the lethal model at 10 dpi compared to the nonlethal models at 14 and 21 dpi; significant increases in IL2-TNF-IFN
production were observed in the lethal model at 10 and 14 dpi compared to the nonlethal model at 21 dpi. (B,C) In both
interstrain comparisons, significant increases in IFN-IL2 and IL2-TNF-IFN were observed in the lethal model at 10 and 14
dpi when compared to nonlethal models at both 10 and 21 dpi. Significant differences between average cytokine populations
in the lethal and nonlethal models are indicated by asterisks (*, p < 0.05).

The CD4+ T-cell cytokine signature associated with the nonlethal infection model was
defined by significant differences in IL2 and IL2-TNF cytokine populations observed in the
interstrain comparisons between the lethal and nonlethal models (Figure 8). Significant
increases in IL2 and IL2-TNF populations were observed in the nonlethal models (Woods IP
and ID) at 21 dpi compared to the lethal model (Karp IP) at both 10 and 14 dpi. Significant
nonlethal (protective) CD4+ T-cell cytokine signatures were not observed in the intrastrain
comparisons of the lethal versus the nonlethal model.
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Figure 8. CD4 nonlethal (protective) cytokine signature. Significant differences in IL2 and IL2-TNF cytokine populations
were observed in the interstrain comparisons between the lethal and nonlethal models. Significant increases in IL2 and
IL2-TNF populations were observed in the nonlethal models at 21 dpi compared to the lethal models at both 10 and 14 dpi.
Significant differences between average cytokine populations in the lethal and nonlethal models are indicated by asterisks
(*, p < 0.05).

Significant differences between the CD8+ T-cell cytokine populations of the lethal and
nonlethal groups were less numerous. A single producer (TNF) cytokine signature was
observed in both of the interstrain comparisons; significant increases in TNF producing
CD8+ T-cells were observed in the lethal model at 14 dpi when compared to the nonlethal
models at 21 dpi (Figure 9). Concurrently, we also observed a significant increase in the
overall frequency of CD8+ T-cells in the lethal model at 14 dpi (Figure 9). These significant
increases were not observed in the lethal models at 10 dpi.

Figure 9. CD8 lethal cytokine signature. Significant differences in CD8 populations and TNF cytokine populations were
observed in interstrain comparisons between the lethal and nonlethal models. In both interstrain comparisons, significant
increases in CD8+ cells and TNF producing cells were observed in the lethal model at 14 dpi when compared to nonlethal
models 21 dpi. Significant differences between average cytokine populations in the lethal and nonlethal models are indicated
by asterisks (*, p < 0.05).

Significant differences in the CD8+ IL2-TNF cytokine populations were observed in
the interstrain comparisons; in particular, increases in IL2-TNF cytokine populations were
observed in the nonlethal models (protective signature) in both interstrain comparisons
(Figure 10). A significant increase in the IL2-TNF population was observed in the Woods
IP nonlethal model at 21 dpi compared to the lethal model at 10 dpi (a slightly significant
increase (p = 0.06) was also observed in the Woods IP nonlethal model at 21 dpi when
compared to the lethal model at 14 dpi.). The significant increase in the CD8+ T-cell IL2TNF population was also significantly increased in the Woods ID nonlethal model at 21 dpi
compared to the lethal model at both 10 and 14 dpi (Figure 10).
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Figure 10. CD8 nonlethal (protective) cytokine signature. Significant differences in IL2-TNF cytokine populations were
observed in the interstrain comparisons between the lethal and nonlethal models. A significant increase in the IL2-TNF
population was observed in the nonlethal IP model at 21d compared to the lethal model at 10 dpi. A significant increase
in the IL2-TNF population was observed in the nonlethal ID model at 21dpi compared to the lethal model at both 10 and
14 dpi. Significant differences between average cytokine populations in the lethal and nonlethal models are indicated by
asterisks (*, p < 0.05).

3.6. Cytokine Signature Correlation to Bacterial Load
To determine if significant correlations existed between the identified signature CD4+
and CD8+ T-cell cytokine populations and splenic bacterial loads, Spearman’s correlation
was used to analyze the potential relationship to disease activity. Correlation analysis
was performed for all identified cytokine signatures, including: (1) CD4 lethal—IFNγ-IL2
and IL2-IFNγ-TNF; (2) CD4 nonlethal—IL2 and IL2-TNF; (3) CD8 lethal—TNF; and (4)
CD8 nonlethal—IL2-TNF. No significant correlations between splenic bacterial load(s) and
cytokine signatures were observed in any of the comparisons (data not shown).
4. Discussion
The purpose of this study was to identify the Th1-associated cytokine signatures of
multifunctional T-cells (CD4+ or CD8+) in both lethal and nonlethal models of O. tsutsugamushi, in an effort to better define/refine the T-cell immune response associated with scrub
typhus infections that range from mild to severe. Clinically, scrub typhus presents with flulike symptoms, and in severe cases, pneumonia, renal failure, meningitis, gastrointestinal
bleeding, and multi-organ failure can occur [38]. Because the early clinical presentation of
scrub typhus is non-specific in nature and because of a lack of sensitive laboratory diagnostics for the first 5 days of disease presentation, misdiagnosis, delayed treatment, and/or
inappropriate antibiotic administration can often be the cause for severe manifestations of
the disease. Moreover, reports of scrub typhus failing to respond to antibiotic treatment
have become more widespread in recent years [11,39]. The geographic distribution of O.
tsutsugamushi comprises an area designated as the “Tsutsugamushi triangle”, which includes Pakistan [40], India [41], Nepal [42], Japan [43], Russia [44], Taiwan [45], China [46],
Korea [47], Indonesia [48], Philippines [49], Thailand [50], and northern Australia [51].
Estimates suggest that O. tsutsugamushi causes one million clinical cases of scrub typhus
per year and that approximately one billion people are at risk of contracting the disease [29].
Currently, reemergence of scrub typhus has been documented in regions of India, Nepal,
Micronesia, and the Maldives [52]. More alarming, evidence of scrub typhus cases occurring in the Middle East [5], South America [53–55], and Africa [56–58] have recently
been reported. The orientiae identified from United Arab Emirates [5] and Kenya [59]
(Candidatus Orientia chuto), and from Chile (Candidatus Orientia chiloensis) [60] have been
found to be related to, but significantly different from O. tsutsugamushi. Therefore, the
emergence of scrub typhus cases poorly responsive to standard antibiotic treatment, large
estimates of populations at risk for contraction of scrub typhus, the recently reported
outbreaks, and the identification of the disease far from the Tsutsugamushi triangle all
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underscore the need for the development of new therapeutics, enhanced diagnostics, and
ultimately a broadly protective vaccine.
To investigate host immune responses to scrub typhus that are associated with lethality
and protection, we utilized a virulent strain (Karp) and a mildly virulent strain (Woods) of
O. tsutsugamushi in a CD-1 outbred mouse model, challenged either intraperitoneally or
intradermally, as previously described [34,61]. Karp IP challenge results in severe illness in
mice beginning at 10 dpi, which becomes exacerbated by 14 dpi; therefore this challenge
model and the associated time points were used to determine the cytokine signatures
associated with lethal O. tsutsugamushi infection. By contrast, Karp ID, Woods IP, and
Woods ID challenges result in milder observed infection in mice; hence the significant
cytokine signatures associated with the Karp ID, Woods ID, and Woods IP models, when
compared to the lethal models, were defined as signatures of nonlethality (protection).
We monitored the physical signs of illness in all groups of mice, bacterial trafficking to
multiple organs, and seroconversion in order to discern the course of infection associated
with each challenge group. The severity of the course of infection was used as a parameter
in order to delineate the challenge groups that would be used to determine the lethal
and nonlethal (protective) T-cell cytokine signatures. In all challenge groups (Karp IP,
ID and Woods IP, ID) we observed physical symptoms of illness, with the most severe
and earliest onset occurring in the Karp IP challenge group; symptoms began at 7 dpi
and were very severe by 12 dpi. In the nonlethal challenge groups, we also observed
outward physical symptoms of illness (ruffling of fur and abdominal bloating); however
these symptoms began later (17–19 dpi) than those observed in the lethal challenge group.
Similarly, enhanced symptoms of organ involvement were observed in the lethal compared
to the nonlethal challenge groups, including splenomegaly, fluid accumulation in the
peritoneum, paling color of the liver, kidney, heart, and enlargement of the liver and lungs.
Splenomegaly was observed in all of the nonlethal challenge groups, starting at 10 dpi and
continuing to 21 dpi, and accumulation of fluid in the peritoneum was observed at 10 dpi.
Bacterial trafficking to the spleen, liver, lung, kidney, and heart was also observed in both
the lethal and nonlethal challenge groups throughout the course of the experiment. Average
increased bacterial loads were observed in the lethal model at all time points compared to
the nonlethal models, however the lungs in all challenge groups were among the organs
containing the highest average bacterial loads, as has been previously reported for other
murine models of O. tsutsugamushi infection [32,37,62,63]. Although average increased
bacterial loads were observed in all organs in the lethal group, significant increases in
average bacterial loads were only detected in the livers and/or hearts of the lethal challenge
group. Seroconversion (total IgG) was detected in 100% of mice in all challenge groups by
21 dpi (titers of 1600 or 6400). Mice in the lethal challenge group (Karp IP) seroconverted
earlier than all other challenge groups (14 dpi, titers of 1600). The combined observations
of physical symptoms of infection, bacterial trafficking, and the humoral immune response
allowed us to characterize the differential levels of severity associated with the lethal and
nonlethal models of O. tsutsugamushi, as well as conclude that while the infection kinetics
may differ between the two models, the elicited immune response and bacteremic levels
are measurable and detectable throughout the course of both the lethal and nonlethal
infection(s).
The observation of differential infection kinetics led us to hypothesize that distinct
T-cell associated cytokine signatures could be prescribed to the lethal and nonlethal models
of infection by identifying the significantly elevated T-cell associated cytokine populations in both models of infection. In particular, we were interested in determining if
differential frequencies of multifunctional T-cells were elicited in the lethal and nonlethal
challenge groups. Multifunctional T-cells (CD4+ and CD8+) have been implicated in both
a protective (vaccine-induced and/or latent infections) as well as acute infection capacity during the immune response to various intracellular pathogens including Mycobacterium tuberculosis [64–67], Francisella tularensis [68], Salmonella typhimurium [69], Leishmania
spp. [70,71], Chlamydia spp. [72] Varicella Zoster Virus [73], Human/Simian Immunodefi-
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ciency Virus [74], Hantaan Virus [75], and Ebola Virus [75]. Specifically, the frequencies
of the singular as well as the simultaneous production of combinations of the Th1 cytokines IFNγ, IL2, and TNF-α have been attributed to immune correlates of protection or
acute illness in the aforementioned studies. Accordingly, we examined the seven possible
combinations of these three cytokines (IFNγ, IL2, TNF, IFNγ-IL2, IFNγ-TNF, IL2-TNF,
IL2-TNF-IFNγ) in both the lethal and nonlethal models of O. tsutsugamushi infection, and
determined which combinations served as signatures in each model.
In the lethal challenge group, we observed a dominance CD4+ T-cell populations
composed of triple- and double-producing cells. Among these observed differences, significant increases in CD4+ T-cell populations producing IFNγ-IL2 and IL2-TNF-IFNγ were
signatures of the lethal challenge group in both intra- and interstrain comparisons (Table 3).
The significantly increased frequency of CD4+ T-cell populations that produced IFNγ-IL2
and IL2-TNF-IFNγ was detected starting at 10 dpi in the lethal group in both intra- and
interstrain comparisons and remained significantly increased above all nonlethal challenge
groups for the duration of the experiment (21 dpi). It has previously been demonstrated
that the frequencies of these two specific populations of CD4+ multifunctional T-cells are
correlated with active and/or latent disease status compared to uninfected and/or healthy
controls. Triple-producing CD4+ T-cells have been correlated as markers of disease activity
in cases of active tuberculosis [65,67,74,76], and CD4+ double producers of IFNγ-IL2 have
also been implicated in increased/chronic disease activity and/or before administration
of treatment(s) during active and latent tuberculosis infections [67,77,78]. T-cell differentiation has been hypothesized to occur in a linear fashion that is influenced by antigen
exposure/stimulation, with progressive gains in functionality of the cells as they reach
their peak of effector function optimization [79]. The generation of triple-producing CD4+
T-cells by continued antigenic stimulation was shown to lead to the generation of multifunctional central memory cells; however, continued antigenic stimulation was shown
to be followed by a loss of memory potential as cells transitioned to a double production
state (IFNγ-IL2) and ultimately to short-lived IFNγ-single-producing populations [79]. The
finding that demonstrates the significant increase in CD4+ triple- and double-producing
T-cells in the lethal O. tsutsugamushi model at the commencement and height of severe
disease may suggest that a progressive loss of functionality of these populations is occurring as the infection progresses. Discrete detailing of the frequencies of triple, double, and
ultimately single-producing (IFNγ) CD4+ T-cell populations at additional time points will
be necessary for the full validation of this hypothesis. However, these data do suggest
that elicitation of triple (IL2-TNF-IFNγ), double (IFNγ-IL2), and potentially single (IFNγ)
CD4+ T-cell populations during O. tsutsugamushi vaccine candidate assessment may not
offer the protective efficacy as previously described for other intracellular vaccine candidates [71,80,81]. As an additional consideration, the possibility exists that the enhanced
production of these Th1 proinflammatory cytokine populations is contributing to the development of an aberrant cytokine storm leading to tissue destruction and consequent death
in the host, as has been described for other mouse models of O. tsutsugamushi [82] and the
closely related R. conorii [83].

Trop. Med. Infect. Dis. 2021, 6, 121

16 of 23

Table 3. Summary of the CD4+ T-cell population lethal and nonlethal (protective) cytokine signatures.
Comparisons between lethal (Karp IP) and nonlethal (Karp ID, Woods IP, Woods ID) challenge models
were performed in an intra- and interstrain fashion. Lethal signatures are designated by an asterisk
(*) and nonlethal (protective signatures) are indicated by a hashtag (#), each indicating a significant
increase (p < 0.05) in the associated population of cytokine-producing cells.
Karp IP vs Karp ID

IFN

IL2

TNF

IFN-IL2

10d vs 14d

*

10d vs 21d

*

IFN-TNF

IL2-TNF

*

14d vs 21d
Karp IP vs Woods IP

IL2-TNF-IFN

*
IFN

IL2

TNF

10d vs 10d

IFN-IL2

IFN-TNF

IL2-TNF

*

IL2-TNF-IFN
*

10d vs 21d

#

*

#

*

14d vs 21d

#

*

#

*

IL2-TNF

IL2-TNF-IFN

Karp IP vs Woods ID

IFN

IL2

10d vs 10d

TNF

IFN-IL2

IFN-TNF

*

*

10d vs 21d

#

*

#

*

14d vs 21d

#

*

#

*

In the nonlethal model, CD4+ T-cell triple-producing cytokine populations were
outnumbered by a dominance of double-producing populations as well as single producers.
Specifically, there was a significant increase in the frequency of CD4+ T-cell populations
that produced IL2 and IL2-TNF in the nonlethal models at 21 dpi compared to the lethal
models at 10 and 14 dpi during interstrain comparison (Table 3). It is well known that IL2
has an important role in the expansion of T-cell populations, has been correlated with T-cell
functional quality, and is often a dominant cytokine during antigen clearance [64,84]. TNFα has been shown to be a component of killing/control during O. tsutsugamushi [85–87]
infections, and during infection with other intracellular pathogens [88–92], either alone or
synergistically with IFNγ or IL2. The presence of multifunctional CD4+ T-cells that are
double producers of IL2-TNF as well as the presence of IL2 single producing cells have
been implicated in a protective capacity during vaccine challenge studies [71,80,93,94],
during therapeutic treatment to prevent active infections [78,95], and in chronic versus
acute infections [96] associated with intracellular pathogens. Vaccine studies related to
intracellular pathogens have demonstrated that a significant elicitation of IL2 and IL2-TNF
CD4+ T-cell populations are found in protected individuals and are closely related to the
development/activation of memory T-cell populations (both central and effector) [71,80,93];
additionally, the presence of these cytokine populations has been correlated with the
long term survival of primed T-cells [97,98]. IL2 has been hypothesized to promote the
expansion of cells capable of producing TNF as an effector molecule [93], which aligns
with the observed protective capacity observed with the significant increase in CD4+ T-cell
populations producing IL2 and IL2-TNF in this study as well as other studies [93,99,100].
IL2 producing CD4+ T-cells have also been shown to express CD40L [101], promote the
expansion of antigen specific B-cells, and/or supplement follicular Th cells to propel
germinal center reactions [101–103]. Moreover, the level of antigenic stimulation can lead
to exhaustion of T-cell populations; comparatively, low-level/slow antigen release can
help to promote development of memory responses. In this study, the significant increase
in IL2 and IL2-TNF was observed using the nonlethal intradermal challenge model. A
commonality of the nonlethal ID model is the presence of lower levels of bacteria in the
organs throughout the 21 day challenge experiment; therefore it can be hypothesized the
intradermal challenge model allows for a slow release of antigen that better permits the
development of CD4+ T-cell populations related to memory. The mechanisms associated
with significant increases in the populations of CD4+ T-cell populations producing IL2
and IL2-TNF necessitate further investigation concerning their role during nonlethal O.
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tsutsugamushi infections. In particular, the development of central versus memory T-cell
populations, the driving of antigen-specific B-cells, and the mode of challenge as potential
mechanisms associated with protection deserve consideration from a pathogenic as well as
a vaccine-development standpoint.
The role of multifunctional CD8+ T-cells and their associated signatures related to the
lethal and nonlethal models of O. tsutsugamushi infections were less numerous; moreover,
the overall numbers of CD8+ T-cells that were elicited in both the lethal and nonlethal
models of infection were reduced in comparison to the CD4+ T-cell populations (Figures 4
and 5). In the lethal model of infection, we did not observe increases in multifunctional
CD8+ T-cell populations when compared to the nonlethal model. Instead we observed
a significant increase in TNF producing populations (along with a concurrent increase
in overall CD8+ T-cell frequency) in the lethal model at 14 dpi (severe illness) when
compared to the nonlethal models at 21 dpi (interstrain comparisons only) (Table 4). It
has been demonstrated that infection with O. tsutsugamushi elicits production of TNF
(associated with both the acute and convalescent immune response) and increases in
CD8+ T-cell populations [62,86,87,104]. Interestingly, we observed the same significant
nonlethal signature associated with CD8+ T-cell populations as compared to CD4+ T-cell
populations; IL2-TNF was found to be significantly increased in the Woods ID nonlethal
model (interstrain comparison) at 21 dpi compared to the lethal model at 10 and 14 dpi,
and in the Woods IP nonlethal model at 21 dpi when compared to the lethal model at
10 dpi (a slightly significant increase (p = 0.06) was observed at 14 dpi). It has recently
been demonstrated in an inbred model of O. tsutsugamushi Karp infection (combined ID
and subcutaneous (SQ) challenge) that CD8+ T-cells contribute to protection against lethal
challenge [62]. Notably, the authors demonstrated that CD8+ T-cells were required to
limit bacterial proliferation during the third week of challenge, that adoptive transfer of
splenic CD8+ T-cells from ID/SQ-challenged mice could protect IP-challenged mice, and
that expanded populations of CD8+ T-cells were needed to prevent recurrent growth of O.
tsutsugamushi during the latent phase of infection [62]. The data from this study combined
with the current observations of significant increases in IL2-TNF producing CD4+ and
CD8+ populations in the nonlethal models of infection at 21 dpi potentially suggests that
the production of IL2-TNF by splenic T-cells may mediate protection via IL2 expansion of
TNF effector cells that may contribute to limiting/controlling bacterial replication and/or
enhance the development of central and effector memory T-cell populations that contribute
to the prevention of recurrent growth of O. tsutsugamushi. Expanded experimentation
defining the associated effector functions and memory phenotypes of multifunctional
T-cells will be imperative to concluding the distinct roles and multifunctional potential
of both CD4+ and CD8+ populations; these characteristics will be useful in the future
development of both vaccines and therapeutics.
In summary, we have shown that multifunctional CD4+ and CD8+ T-cells are elicited
in both the lethal and nonlethal outbred murine models of O. tsutsugamushi infection.
Multifunctional CD4+ and CD8+ T-cells were observed at the beginning and at the height
of severe illness in the lethal model; in the nonlethal models, the multifunctional T-cells
were observed throughout the course of the study (21 days). By comparing the lethal and
nonlethal models, we were able to identify significant cytokine signatures associated with
either lethality or protection. Mechanistic validation of the signatures will be necessary in
order to determine if the identified populations of multifunctional T-cells are involved in
events such as progressive T-cell differentiation and its relation to function, promotion of
the expansion of antigen-specific B-cell populations, and/or the appropriate development
of memory T-cell populations. As a mechanistic correlate of protection, the development
of multifunctional T-cell populations may serve as a parameter of consideration in the
formulation of scrub typhus vaccines. Thus, the cytokine signatures identified in this
study may provide a starting point for evaluation of multifunctional T-cell populations
in additional animal models, as well as in human samples. To fully understand the possible protective capacity of multifunctional T-cells (from a vaccine standpoint), additional
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functions/phenotypic characters (recognition of infected cells, differentiation trends, tissuespecific populations, persistence/memory development, preferential cytokine production
based upon Orientia strain and route of challenge) will require investigation. Moreover,
the populations/roles of innate immune cells as they correlate with multifunctional T-cell
function in response to lethal and nonlethal challenge, as well as the multifunctional T-cell
populations associated with sublethal O. tsutsugamushi challenge will be essential to an
all-inclusive understanding of the murine immune response during scrub typhus infections;
these experiments are currently underway in our laboratory.
Table 4. Summary of the CD8+ T-cell population lethal and nonlethal (protective) cytokine signatures.
Comparisons between lethal (Karp IP) and nonlethal (Karp ID, Woods IP, Woods ID) challenge models
were performed in an intra- and interstrain fashion. Lethal signatures are designated by an asterisk
(*) and nonlethal (protective signatures) are indicated by a hashtag (#), each indicating a significant
increase (p < 0.05) in the associated population of cytokine-producing cells.
Karp IP vs Karp ID

IFN

IL2

TNF

IFN-IL2

IFN-TNF

IL2-TNF

IL2-TNF-IFN

IFN

IL2

TNF

IFN-IL2

IFN-TNF
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